This is with reference to our earlier letter dated April 20, 2023 regarding intimation of Earnings Conference Call ('Con-call') with Investor(s)/ Analyst(s) on April 28, 2023 to discuss financial performance for Q4 FY 2022-23. In this regard, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') (as amended from time to time), please find enclosed herewith the transcript of the said Con-call for your reference. The said transcript of the said Con-call is made available on the Company's website. Further, we hereby confirm that no unpublished price sensitive information was shared or discussed during the said Con-call. Kindly take the same on record.